A recent longitudinal study has uncovered a potential link between vitamin D levels and behavioural impulsivity in women with anorexia nervosa (AN). Conducted at a specialised eating disorder treatment centre, the research suggests that maintaining adequate vitamin D levels may enhance cognitive functions associated with impulse control, potentially offering a new therapeutic avenue for managing this complex disorder. The findings were published in the journal Nutrients.
The study, which assessed 46 cisgender White women, involved comprehensive evaluations upon admission and again after an average inpatient stay of approximately 2.5 months. Participants underwent a range of assessments, including self-reported questionnaires and behavioural tasks, along with measurements of serum vitamin D levels. The primary aim was to explore how changes in vitamin D concentrations might relate to alterations in impulsivity, a trait known to influence the onset and perpetuation of eating disorders.
The results indicated significant improvements in both vitamin D levels and specific measures of impulsivity, such as faster reaction times and fewer errors in the go/no-go task, a common behavioural assessment of impulse control. But using the UPPS-P Impulsive Behaviour Scale, the study found no significant correlation between vitamin D levels and self-reported impulsivity. This discrepancy highlights the importance of using objective behavioural tasks alongside self-report measures to gain a comprehensive understanding of impulsivity in eating disorders.
Notably, the study utilised the Balloon Analogue Risk Task (BART) and the go/no-go task to evaluate impulsivity. The BART measures risk-taking tendencies, while the go/no-go task assesses response inhibition – both critical aspects of impulsivity. The findings revealed that higher vitamin D levels were associated with lower risk-taking behaviours and better response inhibition, suggesting that vitamin D may play a role in modulating these cognitive processes.
The potential therapeutic implications of these findings are significant. Given the high prevalence of vitamin D deficiency among individuals with eating disorders, particularly due to dietary restrictions and reduced sun exposure, addressing this deficiency could become an integral part of treatment strategies. The study’s authors suggest that vitamin D supplementation may serve as an adjunctive treatment, potentially improving both physical health and psychosocial functioning in patients with AN.
The study emphasises the need for further research to explore the underlying mechanisms through which vitamin D influences cognitive functions related to impulsivity. While the current findings are promising, the researchers caution that more rigorous studies, including randomised clinical trials, are necessary to establish causal relationships and validate the therapeutic potential of vitamin D in managing eating disorder symptoms.
The study’s authors acknowledge several limitations, including the exclusive focus on female cisgender White participants, which limits the generalisability of the findings. Additionally, the relatively small sample size may affect the robustness of the results. Future research should aim to include more diverse populations and larger sample sizes to confirm and extend these findings.
Another area for further exploration is the long-term sustainability of the observed effects of vitamin D supplementation on impulsivity and other cognitive functions in AN. Given the complex interplay between various neuropsychological factors in eating disorders, a more nuanced understanding of how vitamin D interacts with other neuropeptides and neurotransmitter systems is crucial.
